162 results
Page 3 of 9
424B5
qv1b43
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
3qqrvybn
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
xr9tl94v i6uaq77qr
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
7lb9wghhe6w02vn7awh
3 Jun 20
Current report (foreign)
8:30am
424B5
3556mm
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
4323wayk26g
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
guretwx
28 May 20
Current report (foreign)
11:56am
6-K
EX-10.3
3nn02
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
80lv9zqvgt1u
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
0tz4qlhp6b7ttnl
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
b9moo
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99
2onufed
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
F-3
g0hve4m32jtf
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-10.2
bg9k5sh4i6ppuv5gt
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
9d0jmnm5dyurca
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am